Group structure
8 companies in 7 countries
Loading your pageโฆ
8 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 329
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIFEDCompressa | Pseudoephedrine, Triprolidine | Italy | Authorised | |
| ACTIFED COMPOSTOSciroppo | Triprolidine, Pseudoephedrine, Dextromethorphan | Italy | Authorised | |
| ACTIFED DECONGESTIONANTESpray nasale, soluzione | Xylometazoline | Italy | Authorised | |
| ACTIGRIPCompressa | Triprolidine, Pseudoephedrine, Paracetamol | Italy | Authorised | |
| ACTIGRIP GIORNO & NOTTECompressa | Paracetamol, Pseudoephedrine, Diphenhydramine | Italy | Authorised | |
| ACTIGRIP TOSSE MUCOLITICOSoluzione orale | Guaifenesin | Italy | Authorised | |
| ACTISINUCompressa rivestita con film | Ibuprofen, Pseudoephedrine | Italy | Authorised | |
| AVEENO ANTI-ITCH LOTION3 % / w/w + 1 % / w/w ยท Lotion | Calamine, Pramocaine | Canada | Marketed | 2000 |
| AVEENO DAILY MOISTURIZING FACE LOTION2.5 % / w/w + 6 % / w/w + 4.5 % / w/w + 8 % / w/w ยท Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canada | Authorised | |
| AVEENO DAILY MOISTURIZING FACE LOTION SPF 303 % / w/w + 7.3 % / w/w + 5 % / w/w + 8 % / w/w ยท Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canada | Authorised | |
| AVEENO POSITIVELY RADIANT DAILY MOISTURIZER SPF 153 % / w/w + 11.5 % / w/w + 5 % / w/w + 3 % / w/w ยท Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canada | Marketed | 2023 |
| AVEENO POSITIVELY RADIANT DAILY MOISTURIZER SPF 301.5 % / w/w + 5 % / w/w + 4 % / w/w + 6 % / w/w ยท Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canada | Marketed | 2023 |
| BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC500 unit / g + 10000 unit / g ยท Ointment, Pad | Bacitracin, Polymyxin b | Canada | Marketed | 1998 |
| BENADRYL ALLERGY25 mg ยท Tablet | Diphenhydramine | Canada | Marketed | 1993 |
| BENADRYL ALLERGY LIQUID12.5 mg / 5 ml ยท Solution | Diphenhydramine | Canada | Marketed | 1994 |
| BENADRYL ALLERGY LIQUIGELS25 mg ยท Capsule | Diphenhydramine | Canada | Marketed | 2008 |
| BENADRYL ALLERGY, SINUS & PAIN TOTAL500 mg + 25 mg + 30 mg ยท Tablet | Paracetamol, Diphenhydramine, Pseudoephedrine | Canada | Marketed | 2004 |
| BENADRYL BUG BITE RELIEF2 % / w/v + 0.1 % / w/v ยท Solution | Diphenhydramine, Zinc | Canada | Marketed | 2007 |
| BENADRYL ITCH STOPPING CREAM2 % + 0.1 % ยท Cream | Diphenhydramine, Zinc | Canada | Marketed | 2020 |
| BENALET | Diphenhydramine, Cloreto amรดnio, Citrato de sรณdio | Brazil | Authorised | 2023 |
| BENALET TSC | Dextromethorphan | Brazil | Authorised | 2023 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH500 mg + 15 mg + 100 mg + 30 mg ยท Tablet | Paracetamol, Dextromethorphan, Guaifenesin, Pseudoephedrine | Canada | Marketed | 1997 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT500 mg + 25 mg + 30 mg ยท Tablet | Paracetamol, Diphenhydramine, Pseudoephedrine | Canada | Marketed | 2005 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU500 mg / 15 ml + 15 mg / 15 ml + 100 mg / 15 ml + 30 mg / 15 ml ยท Syrup | Paracetamol, Dextromethorphan, Guaifenesin, Pseudoephedrine | Canada | Marketed | 2003 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU NIGHT500 mg / 15 ml + 2 mg / 15 ml + 15 mg / 15 ml + 100 mg / 15 ml + 30 mg / 15 ml ยท Syrup | Paracetamol, Chlorpheniramine, Dextromethorphan, Guaifenesin, Pseudoephedrine | Canada | Marketed | 2005 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 186 | 184 | 2 | CompaniesAll medicines |
| Brazil | 59 | 10 | 49 | CompaniesAll medicines |
| United States | 35 | 35 | 0 | CompaniesAll medicines |
| Netherlands | 28 | 28 | 0 | CompaniesAll medicines |
| Italy | 19 | 19 | 0 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.